Tenet Healthcare Reports Strong Q4 2025 Results with Revenue Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 11 2026
0mins
Should l Buy THC?
Source: Businesswire
- Significant Revenue Growth: In Q4 2025, Tenet Healthcare reported net operating revenues of $5.527 billion, an 8.9% increase from $5.073 billion in Q4 2024, indicating strong demand in acute care and ambulatory surgical services, thereby enhancing its competitive position in the market.
- Net Income Performance: The company achieved a net income of $371 million in Q4 2025, up 16.7% from $318 million in the same quarter last year, reflecting improved operational efficiency and effective cost control, which is expected to positively impact future shareholder returns.
- Adjusted EBITDA Growth: The adjusted EBITDA for Q4 reached $1.183 billion, a 12.8% increase from $1.048 billion in Q4 2024, indicating ongoing improvements in profitability across all business segments, which will support the achievement of financial targets for 2026.
- Optimistic 2026 Outlook: Tenet projects net operating revenues for 2026 to be between $21.5 billion and $22.3 billion, with adjusted EBITDA expected to reach between $4.485 billion and $4.785 billion, demonstrating the company's confidence in future growth and plans to enhance service quality and market share through continued investment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy THC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on THC
Wall Street analysts forecast THC stock price to rise
10 Analyst Rating
10 Buy
0 Hold
0 Sell
Strong Buy
Current: 191.860
Low
229.00
Averages
242.89
High
260.00
Current: 191.860
Low
229.00
Averages
242.89
High
260.00
About THC
Tenet Healthcare Corporation is a diversified healthcare services company. The Company's segments include Hospital Operations and Services (Hospital Operations) and Ambulatory Care. The Hospital Operations segment is comprised of its acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities. The Company's subsidiaries operate approximately 49 hospitals serving primarily urban and suburban communities in eight states. The Hospital Operations segment also includes around 135 outpatient facilities, including urgent care centers, imaging centers, off-campus hospital emergency departments and micro hospitals. It also provides revenue cycle management and value based care services. The Ambulatory Care segment, through its USPI Holding Company, Inc. subsidiary, holds ownership interests in approximately 518 ambulatory surgery centers, and 25 surgical hospitals in 37 states. The Company operates a Global Business Center in the Philippines.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Legal Challenge Intensifies: The Supreme Court is set to hear arguments on President Trump's executive order to end birthright citizenship this Wednesday, marking one of the most significant constitutional challenges of the 2026 term that could affect millions of children born in the U.S.
- Core Constitutional Dispute: The case centers on the Citizenship Clause of the 14th Amendment, which states that 'all persons born or naturalized in the United States are citizens,' while the Trump administration seeks to adopt a narrower 'jurisdictional' theory that would exclude children of those without legal status.
- Market and Policy Implications: A ruling in favor of Trump's policy could create immediate administrative and economic ripple effects, impacting areas such as healthcare eligibility and future labor force projections, potentially leading to significant adjustments in social service systems.
- Political and Judicial Independence: The timing of the case is sensitive, as Trump has escalated his criticism of the judiciary, and legal analysts suggest this case could serve as a political tool for him, potentially resulting in a landmark victory for his immigration agenda or framing the conservative-led court as an obstacle to his domestic security goals.
See More
- Analyst Rating Changes: Top Wall Street analysts have adjusted their outlook on MU stock, indicating a shift in market sentiment, although specific rating changes were not detailed in the report.
- Increased Market Attention: As analysts focus more on MU stock, investors may reassess their investment strategies, potentially impacting the stock's market performance and price volatility.
- Impact of Rating Changes: Changes in analyst ratings typically have a direct effect on investor confidence, which could lead to increased buying or selling pressure on MU stock, thereby influencing its short-term price movements.
- Information Transparency: Despite the lack of specific rating change details, the market remains highly attentive to analysts' views, reflecting potential uncertainty regarding MU's future performance.
See More
Positive Market News: Despite recent negative headlines regarding Iran, oil prices, market losses, and poor job numbers, there is encouraging news in the financial sector.
High-Performing Funds: Five investment funds are currently performing exceptionally well, providing a bright spot in an otherwise challenging economic landscape.
See More
- Weak Job Market: The U.S. nonfarm payrolls unexpectedly fell by 92,000 in February, significantly below the forecast of 50,000 and down from the revised January total of 126,000, indicating ongoing economic pressure from severe winter weather and a strike in the healthcare sector.
- Rising Unemployment Rate: The unemployment rate increased to 4.4%, reflecting job losses across key sectors, although a broader measure of unemployment, which includes discouraged workers and part-time workers for economic reasons, decreased to 7.9%, suggesting some resilience in the labor market.
- Wage Growth Exceeds Expectations: Despite the weak job data, average hourly earnings rose by 0.4% for the month and 3.8% year-over-year, both exceeding forecasts by 0.1 percentage points, indicating persistent labor cost pressures that could influence future monetary policy decisions.
- Significant Industry Impact: The healthcare sector lost 28,000 jobs due to the Kaiser Permanente strike, while information services and manufacturing saw declines of 11,000 and 12,000 jobs respectively, highlighting structural challenges within industries that may lead policymakers to adopt a more cautious approach in response to economic slowdown.
See More
- Job Growth Overview: According to the ADP report, the private sector added a seasonally adjusted 63,000 jobs in February, a significant improvement from the revised 11,000 in January and surpassing the Dow Jones estimate of 48,000, indicating resilience in the labor market.
- Sector Contribution Analysis: The education and health services sector led job creation with 58,000 new positions, while construction added 19,000, although most other sectors showed stagnant growth, highlighting the breadth issue in employment gains.
- Wage Growth Trends: Wage growth for job stayers remained steady at 4.5%, while the increase for job switchers fell to 6.3%, indicating that the incentive to change jobs has dropped to the lowest level since ADP began tracking this metric, potentially affecting future job mobility.
- Small Business Performance: Job gains were primarily concentrated in small businesses with fewer than 50 employees, which added 60,000 jobs, while large firms (500 or more employees) only added 10,000, reflecting the relative dynamism of small businesses in the current economic environment.
See More
- Strong Earnings Report: Tenet Healthcare reported $5.5 billion in revenue for Q4 2025, reflecting approximately 14% year-over-year growth and exceeding market expectations by $60 million, driven by favorable payer mix and increased disease severity.
- Improved Profitability: The company's non-GAAP EPS rose to $4.70, a 37% increase year-over-year, beating Wall Street forecasts by $0.65, with adjusted EBITDA margin reaching 21.4%, up 70 basis points from the previous year, indicating significant profitability enhancement.
- Positive Market Reaction: Tenet's stock surged nearly 19% on Wednesday, reaching an all-time high, which also boosted shares of major competitors like HCA Healthcare and Universal Health Services, reflecting strong market confidence in its financial performance.
- Future Outlook: Despite projecting a 20% decline in overall enrollments for 2026, Tenet anticipates net operating revenue of $21.9 billion, indicating approximately 4% year-over-year growth, showcasing the company's resilience and market confidence amid challenges.
See More











